Print（PDF/179KB） Apr. 17, 2025 Corporate

Sumitomo Pharma Announces Changes in the Positions Assumed by Executive Officers and Other Key Position

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced the following changes in the positions assumed by Executive Officers and other key position, effective May 1, 2025.

I. Changes in the Positions Assumed by Executive Officers (effective May 1, 2025)

Position as of May 1, 2025	Current position	Name
Managing Executive Officer Special Mission for Asia Business Transition	Managing Executive Officer Business Development & Management Vice President, Head of Business Development & Management Asia Business	Shigeyuki Nishinaka
Executive Officer Business Development & Management; Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit	Executive Officer Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit	Koichi Kozuki
Executive Officer Senior Vice President, Deputy Head of Corporate Regulatory Compliance & Quality Assurance Division Senior Vice President, Deputy Head of Research and Development Division (Drug Discovery Research)	Executive Officer Senior Vice President, Deputy Head of Research and Development Division (Drug Discovery Research)	Isao Shimizu

II. Change in Personnel (effective May 1, 2025)

Corporate Department

Position as of May 1, 2025	Current position	Name
Vice President, Head of Business Development & Management	Vice President, Sumitomo Pharma America, Inc.	Tatsuya Ito